Blood plasma derivatives are complex medicinal products collected from blood plasma that find applications in various therapeutic areas such as neurology, immunology, hematology, critical care medicine and others. They provide proteins for conditions where the body is unable to produce them on its own. Some of the commonly used blood plasma derivatives include immunoglobulins, clotting factors, albumin and hyperimmune globulins. The demand for blood plasma derivatives has significantly increased in recent years due to the rising prevalence of rare blood diseases and growing geriatric population globally.

The global Blood Plasma Derivatives Market is estimated to be valued at US$ 44.33 Bn in 2023 and is expected to exhibit a CAGR of 13% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:

The rising incidence rate of rare bleeding disorders, neurological disorders, immunodeficiency disorders and injury cases have increased the demand for therapeutic proteins significantly in recent years. Blood plasma derivatives play a vital role in treating various rare disorders by providing therapeutic proteins thus representing a major opportunity for growth of the blood plasma derivatives market. According to research organization ORPHAnet, over 7,000 rare diseases have been identified till date and 95% of them have a genetic origin. This increasing incidence rate of various rare diseases is projected to drive the demand for blood plasma derivatives during the forecast period, thereby propelling the market growth.

Porter's Analysis

Threat of new entrants: The Global Blood Plasma Derivatives Market Size requires substantial capital investments for equipment, manufacturing facilities, and compliance with stringent regulations which poses significant barriers for new companies.
Bargaining power of buyers: The demand for blood plasma derivatives is inelastic in nature as they are life saving products. However, buyers can negotiate on pricing and contracts through aggregation of demand.
Bargaining power of suppliers: The suppliers of raw materials including blood plasma have some bargaining power due to concentration of suppliers and requirements for special storage facilities for plasma collection.
Threat of new substitutes: There are limited substitutes available for blood plasma derivatives currently and development of new substitutes require huge investments and time for clinical validation.
Competitive rivalry: The market is highly competitive with major global players competing. Companies compete based on product quality, reliable supply, cost efficacy, and brand recognition.

SWOT Analysis

Strengths: Strong demand for blood plasma derived products to treat various deficiency disorders. Established production, purification and testing technologies.
Weaknesses: Supply chain disruptions can impact availability. High capital investments and operating costs involved.
Opportunities: Growth in developing markets. New product development and applications.
Threats: Stringent regulations. Supply shortages of plasma due to donor availability. Threat from alternative therapies.

Key Takeaways

The global Blood Plasma Derivatives Market is expected to witness high growth at a CAGR of 13% during the forecast period of 2023 to 2030. The market size is projected to reach US$ 44.33 Bn by 2023.

Get More Insights On This Topic: http://medicalinfoblogs.weebly.com/blog/the-global-blood-plasma-derivatives-market-growth-accelerated-by-increasing-demand-for-plasma-derived-medicines